ATE295171T1 - Analgetische zusammensetzung welche moxonidine und ein opioid-analgetika enthält - Google Patents

Analgetische zusammensetzung welche moxonidine und ein opioid-analgetika enthält

Info

Publication number
ATE295171T1
ATE295171T1 AT98117346T AT98117346T ATE295171T1 AT E295171 T1 ATE295171 T1 AT E295171T1 AT 98117346 T AT98117346 T AT 98117346T AT 98117346 T AT98117346 T AT 98117346T AT E295171 T1 ATE295171 T1 AT E295171T1
Authority
AT
Austria
Prior art keywords
analgesic
opioid
composition containing
moxonidine
agent
Prior art date
Application number
AT98117346T
Other languages
English (en)
Inventor
Carolyn A Fairbanks
George L Wilcox
Laura S Stone
Kelley F Kitto
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of ATE295171T1 publication Critical patent/ATE295171T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98117346T 1997-09-16 1998-09-14 Analgetische zusammensetzung welche moxonidine und ein opioid-analgetika enthält ATE295171T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5895497P 1997-09-16 1997-09-16

Publications (1)

Publication Number Publication Date
ATE295171T1 true ATE295171T1 (de) 2005-05-15

Family

ID=22019930

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98117346T ATE295171T1 (de) 1997-09-16 1998-09-14 Analgetische zusammensetzung welche moxonidine und ein opioid-analgetika enthält

Country Status (4)

Country Link
US (1) US6204271B1 (de)
EP (1) EP0906757B1 (de)
AT (1) ATE295171T1 (de)
DE (1) DE69830114D1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3806427B2 (ja) * 2002-01-21 2006-08-09 株式会社Ｎｒｌファーマ 新規鎮痛剤
EP1517688A2 (de) * 2002-06-19 2005-03-30 Solvay Pharmaceuticals GmbH Arzneimittel zur behandlung von eine inhibition oder aktivitätsverminderung von ph-wert-regulierenden bikarbonat-transporter-proteinen erfordernden erkrangungen
US20040161481A1 (en) * 2002-12-18 2004-08-19 Algorx Administration of capsaicinoids
AU2003299691B2 (en) 2002-12-18 2008-06-05 Algorx Pharmaceuticals, Inc. Administration of capsaicinoids
US20050085652A1 (en) * 2003-04-08 2005-04-21 Algorx Pharmaceuticals, Inc. Preparation and purification of synthetic capsaicin
WO2006058140A2 (en) * 2004-11-24 2006-06-01 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
WO2011053705A1 (en) * 2009-10-30 2011-05-05 Janssen Pharmaceutica Nv Pyrimidine compounds as delta opioid receptor modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU166378B (de) * 1972-12-19 1975-03-28
US5840731A (en) * 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain

Also Published As

Publication number Publication date
EP0906757A2 (de) 1999-04-07
US6204271B1 (en) 2001-03-20
EP0906757B1 (de) 2005-05-11
DE69830114D1 (de) 2005-06-16
EP0906757A3 (de) 2001-05-16

Similar Documents

Publication Publication Date Title
DE69536035D1 (de) Schmelzextrudierte oral verabreichbare Opioidformulierungen
DE69822168D1 (de) Dentale anästhesie- und verabreichungsinjektionseinheit
NZ503233A (en) Synergistic analgesic combination of opioid analgesic and COX-2 inhibitor
HUP0002645A3 (en) Phospholipid containing pharmaceutical composition for treating sleep apnea and apparatus for enabling the administration thereof
ATE210983T1 (de) Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum
FI954228A0 (fi) Infuusiolaite hoitoaineen jaksottaista tai jatkuvaa antamista varten
NZ336865A (en) Use of a therapeutic agent containing a neurotrophic factor for treatment of diabetes and hyperlipemia
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
EP0761173A3 (de) Nadel zum Verabreichen therapeutischer Lösungen in den Subarachnoidalraum
ATE283695T1 (de) Verwendungen und zusammenstellungen von nitratestern als sedativa
PT957899E (pt) Forma de dosagem para proporcionar um medicamento numa dose crescente
ATE243196T1 (de) Piperidine und pyrrolidine
ES2099344T3 (es) Preparado de combinacion a base de flupirtina y morfina para el tratamiento de dolores y para evitar la adiccion a morfina.
EE04493B1 (et) Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks
EP0683668A4 (de) Präparate und verfahren für eine transdermale arzneistoffverabreichung.
DE69830114D1 (de) Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält
ITMI931325A0 (it) Composizione farmaceutica ad attivita' analgesica
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
FI964619A7 (fi) Epilepsialääkkeiden iholle annostelu
UA37278C2 (uk) Протикашльова фармацевтична композиція для перорального введення
EE03205B1 (et) Ropivakaiini kasutamine valuvaigistina kasutatava ravimpreparaadi valmistamiseks
DK408188D0 (da) Injicerbart middel til kontrolleret frigivelse af opioid-analgetika
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
SE9803623D0 (sv) New therapeutic application
IT1288708B1 (it) Composizione farmaceutica comprendente trometamina per il trattamento per via topica dell'acne vulgaris.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0906757

Country of ref document: EP

REN Ceased due to non-payment of the annual fee